Pharmalittle: We're Reading About a Bidding War for Metsera, HHS Plans for Speeding Biosimilars, and More

Novo and Pfizer Spar Over Metsera in Search for Obesity Drugs

Get caught up

Pharmalittle: We're reading about a bidding war for Metsera, HHS plans for speeding biosimilars, and more

Thermo Fisher Scientific agreed to buy Clario Holdings, which makes software used in clinical trials, for about $8.9 billion

Novo Nordisk seeks to “suppress competition” with startup bid, Pfizer says

Pfizer has accused Ozempic manufacturer Novo Nordisk of launching a bidding war for a startup working on a new weight loss drug to harm competition whilst evading regulatory scrutiny. 

Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing

Two of the world’s largest pharmaceutical companies, Pfizer (New York, US) and Roche (Basel, Switzerland), have unveiled more than $10bn in biotech acquisitions within days of each other, emphasising the intensifying competition in obesity and liver disease therapies and highlighting how US policy on manufacturing, tariffs, and drug pricing may be reshaping global pharma strategy.